论文部分内容阅读
非小细胞肺癌是全球发病率最高的癌症之一,约80%肺癌为非小细胞肺癌(non smallcelllungcancer,NSCLC),其中70%～80%发现时已经失去手术机会,只能采取以化疗为主的综合治疗。吉西他滨是目前治疗非小细胞肺癌最有效的化疗药物之一,随机研究证实吉西他滨与顺铂联合用药对于进展期
Non-small cell lung cancer is one of the most frequently occurring cancers in the world. About 80% of lung cancer is non small cell lung cancer (NSCLC). 70% to 80% of them have lost the chance of surgery and can only be treated with chemotherapy Comprehensive treatment. Gemcitabine is currently one of the most effective chemotherapy drugs for the treatment of non-small cell lung cancer. Randomized studies have confirmed that gemcitabine and cisplatin combination therapy for advanced stage